Triple Metabolic Incretin Stack (Reta + Cagri + AOD)
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
Pharmacological Profile & Mechanism of Action
What it is: The Triple Metabolic Incretin Stack is an analytical multi-vial research kit containing Retatrutide (10 mg), Cagrilintide (5 mg), and AOD-9604 (5 mg) in 3 separate lyophilized vials (20 mg total).
How it works: Retatrutide engages GIP, GLP-1, and glucagon receptors for profound energy expenditure and glycemic stability; Cagrilintide engages central amylin receptors to induce durable postprandial satiety; and AOD-9604 acts peripherally on adipocyte beta-3 receptors to accelerate triglyceride breakdown without glycemic disruption.
Why researchers study it: Researched as the most comprehensive multi-pathway metabolic standard in contemporary pharmacological research, addressing appetite, insulin sensitivity, thermogenesis, and direct adipocyte lipolysis.
